AdvanDx, Inc.

41 articles about AdvanDx, Inc.

• AdvanDx, Inc. Receives FDA 510(k) Clearance For mecA XpressFISH

  11/18/2014

• Data From Thirteen Studies Highlighting AdvanDx, Inc.'s Infectious Disease Assays To Be Presented At The 114th General Meeting Of The American Society of Microbiology (ASM)

  5/19/2014

• AdvanDx, Inc. Raises $12 Million To Accelerate The Expansion Of The Company's Molecular Diagnostic Product Offerings

  4/8/2014

• AdvanDx, Inc. Announces FDA 510(K) Submission For Meca Xpressfish™ -- A New Method For Rapid Detection Of Methicillin-Resistant Staphylococcus Aureus (MRSA) From Positive Blood Cultures

  3/18/2014

• AdvanDx, Inc. Adds Gram-Negative BC Assay to U.S. and E.U. Commercial Launch of QuickFISH(TM) - a 20 Min. Pathogen ID Platform for the Identification & Treatment of Sepsis

  9/25/2013

• AdvanDx, Inc. Elects Former Roche Molecular Systems, Inc. CEO, Heiner Dreismann, Ph.D., to Its Board of Directors

  3/27/2013

• AdvanDx, Inc. Adds Enterococcal Bacteremia Assay to U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID) Platform

  1/10/2013

• AdvanDx, Inc. Announces U.S. and E.U. Commercial Launch of QuickFISH™ (20 Min. Pathogen ID), the First Molecular Test to Enable Reporting of Pathogen Identification at the Time of Gram Stain Results From Positive Blood Cultures

  9/10/2012

• AdvanDx, Inc. to Unveil QuickFISH™ (20 Min. Pathogen ID) at ECCMID 2012

  3/15/2012

• AdvanDx, Inc. Release: New Study Shows PNA FISH(R) Test Reporting Dramatically Decreased Mortality and Hospital Costs for Patients with Bloodstream Infections

  10/13/2011

• AdvanDx, Inc. Receives FDA 510(k) Clearance for GNR Traffic Light(TM) PNA FISH(R)

  1/18/2011

• AdvanDx, Inc. Launches GNR Traffic Light(TM) PNA FISH(R) in Europe

  8/12/2010

• AdvanDx, Inc. Launches GNR Traffic Light(TM) PNA FISH(R) in Europe

  8/12/2010

• AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes Protocol for Yeast Traffic Light(R) PNA FISH(R)

  7/29/2010

• AdvanDx, Inc. to Offer BinaxNOW(R) PBP2a Test for Rapid Detection of PBP2a in Methicillin-Resistant Staphylococcus aureus (MRSA)

  5/24/2010

• AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Candida Bloodstream Pathogens

  3/31/2010

• AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Gram-Negative Bloodstream Pathogens

  12/22/2009

• AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens

  12/11/2009

• AdvanDx, Inc. Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Enterococcal Bloodstream Pathogens

  10/27/2009

• AdvanDx, Inc. Raises $8 Million

  8/19/2009